| ˷5 յ 5 Ʈ ˱ Ұϴ ڳԴϴ.
1. 7000 Ȯ ϴǾǰ ֵ̿ Ȯ 𰡴 (7000~8000 ϴ 7000̴. 6~7 俹 ߰ 13~14 Ϲ û 24 ڽ 忡 (ڳؽ ) ̴. ְ ̴.
俹 ߴ ̿( 2, 1600 : 1) ȴ. ֵ̿ 俹 283 ߰ 102 1 ߴ. 𰡷 7000 60.28% Ҵ. ǹȮ û .
ֽļ 136( 100%)̸ 95 ̴. ֵ̿ ڴ "ȸ簡 غ IgYǰ IgYǰ 꼳 Ȯ 3 "̶ " 2021 5 ڹ ȯä 45 õÿ ű (õ) Ȯ, 2022 踦 ߰ 2023 ϰ ǥ IgY ǰ Ȯ "̶ ߴ.
忹ֽļ ֽ Ͽ 9093844ִ. 39.65% شϴ 3605645ְ ̴. ִִ ȫ ֵ̿ ǥ̻ 24.68%. Ư 8 ϸ 40.68%. ְִ ֽ Ϸκ 3, Ư 1Ⱓ Ű ѵȴ.
2. ֵ̿, 鿪ü ̿
ֵ̿ Ư̳Ȳü(IgY) Ǿǰ ϴ ̴. ü , , 鿡 ϴ ῡ ȥϿ ȭ, , ġḦ ֵ ϴ Ǿǰ(汸ġ) .
ֵ̿ ֿ ǰ Ǿǰ, Ȳ , ȯ ̽ ´. 2021 3б Ǿǰ 63%, 29%. Ǹ ŷó κ ǰ븮 ̴. û ΰ ü Ǹϰ ִ.
2012 5 KvGMP ȹ , Ǿǰ ڵȭ ý ̷ KvGMP ü ϰ ִ. 2020 Ű(2) ϰ߰ ̸ ų ִ 250 ̴. ƿ ȸ ؿ Ǹ ΰ ʿ ǰ Ƿΰ Ȯ Ͽ ̹ IPO ڱ ü Ȯ ȹ̴.
ȸ ȭ , Ȱȭ (whole cell) ܹ ȥ , -ü ü ̿ ܰ IgY ִ Ȯߴ. ϰ ִ 300 ̺귯 ü ż ϴ.
(ڷ : ֵ̿ IR Book)
3. پ Ȯ
ֵ̿ Ѱ踦 غϰ Ǿǰ ٰ ϰ ִ. 2021 10(Ϻ, Ʈ, ʸ ) ̸ 16 ؿܾü ŷϰ ִ. 2020 ߱ ǸŹ ߱ ȭ ̸ Ŀ ȭ ȹ̴.
ƿ Ǿǰ Ǿǰ Ǿǰ Ȯ ȹ̴. Ư , IgY ϰ ȭ ϰ ִ. IgY 2017 6 ±, ʸ, Ǹ(Distributorship) Ϸ ̽þ, Ʈ Ǹ ֹ ּ ϸ 2020 2б ִ.
ȸ " IgY 2Ⱓ ߰ ı ִ ÷ ǰ Ͽ ߱, ±, Ʈ ӻ Ϸ߰ ǽ ̴"鼭 "ڷγ ̽ Ȱ 2022 ̸, ߱ ݵ ʿ ߱ AQ-SIQ ɻ Ϸ ߿ ۿ "̶ ߴ.
IgYι ĥ Ʈʻ 2013 ؿԴ. ֵ̿ ĥ Ʈʻ 迡 ° ϴ ĥ忡 /÷ ȸ. ̵ In-vitro 8In-vivo ģ Field Trial ܰ Final Test غ ̴. Ϸ 2022 ù ȹϰ ִ.
(ڷ : ֵ̿ IR Book)
4. غ
ֵ̿ ڽڽ Ưʸ ڽ 忡 Ѵ. 2020 11 û ѱŷҰ 2 (ѱ, ǿȭ)κ A, BBB 뺸Ҵ. ٸ ߺ ں ս ϰ ִ.
ؿ 忡 Ծ 2018 74 2019 93, 2020 98 ߴ. ȸ "2020 ڷγ ķ ( IgY) ߱ űԻ( IgY ± ) Ͽ " ߴ.
2018 51%, 2019 48%, 2020 55%, 2021 3б 55% ߴ. 2020 2021 3б ڷγ ߱ þ ̴. Ⱓ ߺ ǰ ߰, ̿ 2020 ڸ ߴ.
ȸ ǰ ǰ㰡, ؿܽ Ͽ ߴ. ڼ 2021 130 2022 290(+123% ), 2023 587(+102%) ̴. Բ ũ ٸ ڷ Ƽ δ.
(ڷ : ֵ̿ IR Book)
5. R&D ߽ 濵
ȫ ֵ̿ ǥ̻ б а ̾ 鼭 迡 Ⱓ Ҵ. ֵ̿ ϱ 17Ⱓ Ǿǰ 2000 ǵũ ִ. ϸ鼭 IgY ϰ ư 2001 ֵ̿ , 2003 IgY ߴ.
ֵ̿ ó η ġϰ Ż ϴ ȸ 忡 ߿ Ҵ. ȸ ڻ η ü η 76% ϸ õ , , ü ǰɽǰ ̸ ϰ ִ.
ֵ̿ ߺδ â ̻ ̳ ̻簡 ̲ ִ. ̳ ̻ б ڻ縦 ߰ ѱб, ѱǰ ģ ̿ â߾ 2008 ֵ̿ ̻ ̴. â ̻ 2010~2019 ǰ, Ѿб, б, Ѿб ߰, 2019 ֵ̿ؿ ̻縦 ð ִ.
ȸ ߾ӿҴ Ȳ鿪ü ̿Ͽ Ǿǰ ϰ ִ. 2020 繫ǥ , Ѿ 15(κ ) Ը̸ 15% Ÿ ִ. ܰ ô Ǵ ű Ȯ ߺ Ǵ δ.
( 0)